April 23, 2019
Diplomat Pharmacy has agreed to pay $14.1 million to settle a proposed class action claiming investors were kept in the dark about an increase in fees pharmacy benefits manager CVS Caremark was going to charge for Medicare Part D prescriptions.
November 14, 2016
Specialty drugmaker Diplomat Pharmacy Inc. overestimated its hepatitis C drug's financial outlook and failed to properly calculate $8 million in Medicare fees, causing share values to plummet by 42 percent once news broke, according to a lawsuit filed in Michigan federal court.